FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On June 11, 2007
Docket # Title
1995N-0294 Quality/fill container; common or unusual name regulations
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999N-1415 Supplements and other changes to aproved NADA
2000D-0109 Assessment of Antimicrobial Susceptibility Devices
2002P-0483 Actions re: exceptive drug products, ex release guaifenesin
2003N-0573 Draft Animal Cloning Risk Assessment
2003V-0550 Laser Light Show
2004N-0382 Food Labeling: Safe Handling Statements: Labeling of Shell Eggs
2004P-0006 Stay approval of abbreviated new drug applications for controlled release oxycodone hydrochloride products that list OxyContin oxycodone HCI controlled-release
2005N-0272 Irradiation in the Production, Processing, and Handling of Food
2005N-0279 Food Labeling; Gluten-Free Labeling of Foods
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
2006D-0480 Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration
2006N-0238 Debarment of Maria Anne Kirkman Campbell
2006N-0362 General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device
2006P-0069 Health Claim Petition: Soluble Fiber from Certain Foods and Coronary Heart Disease
2006P-0334 Reclassification Petition fo Bone Heterografts
2007D-0106 Guidance for Clinical Investigators, Sponsors, and IRBs on Adverse Event Reporting Improving Human Subject Protection
2007D-0117 Guidance for Industry on Orally Disintegrating Tablets
2007M-0108 P060019 - Therapy Cool Path Ablation Catheter and IBI 1500T9 RF Ablation Generator
2007N-0114 Electronic Distribution of Prescribing Information for Prescription Drug Products; Public Hearing
2007N-0208 Interim Melamine and Melamine Analogues Safety/Risk Assessment; Availability
2007P-0177 ANADA Suitability for generic new animal drug meloxicam which differs from the pioneer product, Metacam 1.5 mg/mL Oral Suspension
1995N-0294 Quality/fill container; common or unusual name regulations
REF 1 OMB Review Vol #: 7
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 19994 Enzymatic Therapy, Inc. Vol #: 175
LET 19995 Enzymatic Therapy, Inc. Vol #: 175
LET 19996 Enzymatic Therapy, Inc. Vol #: 175
LET 19997 Enzymatic Therapy, Inc. Vol #: 175
LET 19998 Enzymatic Therapy, Inc. Vol #: 175
LET 19999 M. Santana, LLC Vol #: 175
LET 20000 Source Naturals Vol #: 175
LET 20001 Source Naturals Vol #: 175
LET 20002 T & Tea Company Vol #: 175
LET 20003 T & Tea Company Vol #: 175
LET 20004 Enzymatic Therapy, Inc. Vol #: 175
LET 20005 NewMark: A Division of New Chapter, Inc. Vol #: 175
LET 20006 New Chapter, Inc. Vol #: 175
LET 20007 New Chapter, Inc. Vol #: 175
LET 20008 New Chapter, Inc. Vol #: 175
LET 20009 New Chapter, Inc. Vol #: 175
LET 20010 New Chapter, Inc. Vol #: 175
LET 20011 New Chapter, Inc. Vol #: 175
LET 20012 New Chapter, Inc. Vol #: 175
LET 20013 New Chapter, Inc. Vol #: 175
LET 20014 Hillestad Pharmaceuticals Vol #: 175
LET 20015 Attogram Corp. Vol #: 175
LET 20016 Inverness Medical Nutritionals Group Vol #: 175
LET 20017 Inverness Medical Nutritionals Group Vol #: 175
LET 20018 Inverness Medical Nutritionals Group Vol #: 175
LET 20019 Inverness Medical Nutritionals Group Vol #: 175
LET 20020 Inverness Medical Nutritionals Group Vol #: 175
LET 20021 Inverness Medical Nutritionals Group Vol #: 175
LET 20022 Inverness Medical Nutritionals Group Vol #: 175
LET 20023 Inverness Medical Nutritionals Group Vol #: 175
LET 20024 Leland Cherry Company Vol #: 175
LET 20025 HERB PHARM Vol #: 175
LET 20026 Enzymatic Therapy, Inc. Vol #: 175
LET 20027 Lativio LLP Vol #: 175
LET 20028 JOL Management Vol #: 175
LET 20029 Bee-Alive Inc. Vol #: 175
LET 20030 Swanson Health Products Vol #: 175
LET 20031 Futurebiotics LLC Vol #: 175
LET 20032 KHONG GUAN CORPORATION Vol #: 175
LET 20033 Medtech Products, Inc. Vol #: 175
LET 20034 Pharmavite LLC Vol #: 175
LET 20035 Univera LifeSciences, Inc. Vol #: 175
LET 20036 ZeaVision, LLC Vol #: 175
LET 20037 HERB PHARM Vol #: 175
LET 20038 CParmax, Inc. Vol #: 175
LET 20039 Iovate Health Sciences U.S.A. Inc. Vol #: 175
LET 20040 Nutramax Laboratories, Inc. Vol #: 175
LET 20041 Peak Health Care Products, Inc. Vol #: 175
LET 20042 StoneBridge Pharma Vol #: 175
LET 20043 Savvier, LP Vol #: 175
LET 20044 FreeLife International, Inc. Vol #: 175
LET 20045 Leiner Health Products, LLC Vol #: 175
LET 20046 Futurebiotics LLC Vol #: 175
1999N-1415 Supplements and other changes to aproved NADA
REF 3 OMB Review Vol #: 2
2000D-0109 Assessment of Antimicrobial Susceptibility Devices
ACK 1 FDA/DDM to Clinical and Laboratory Standards Institute Vol #: 2
CP 1 Clinical and Laboratory Standards Institute Vol #: 2
2002P-0483 Actions re: exceptive drug products, ex release guaifenesin
PAV 1 FDA/ORA Vol #: 1
2003N-0573 Draft Animal Cloning Risk Assessment
C 1456 J. Ardizzone Vol #: 207
C 1457 B. Pavey Vol #: 207
C 1458 L. Graff Vol #: 207
C 1459 C. Smead Vol #: 207
C 1460 K. Rienks Vol #: 207
C 1461 K. Ray Vol #: 207
C 1462 J. Call Vol #: 207
C 1463 J. Reeds Vol #: 207
C 1464 B. Truman Vol #: 207
C 1465 P. Polizzi Vol #: 207
C 1466 M. Bann Vol #: 207
C 1467 M. Bautel Vol #: 207
C 1468 S. Lonsbury Vol #: 207
C 1469 J. E. Young Vol #: 207
C 1470 M. D. Chapman Vol #: 207
C 1471 S. Perez Vol #: 207
C 1472 K. Inman Vol #: 207
C 1473 B. Paolucci Vol #: 207
C 1474 R. Sorenson Vol #: 207
C 1475 A. Ainsworth Vol #: 207
C 1476 J. Barrios Vol #: 207
C 1477 L. Jaeger Vol #: 207
C 1478 SFC P. Pierce Vol #: 207
C 1479 M. Rivas Vol #: 207
C 1480 A. Fierke Vol #: 207
C 1481 J. Thompson Vol #: 207
C 1482 M. H. Vol #: 207
C 1483 C. Roth Vol #: 207
C 1484 T. Warner Vol #: 207
C 1485 D. Lacey Vol #: 207
C 1486 M. Peek Vol #: 207
C 1487 K. Angus Vol #: 207
C 1488 K. Yoshida Vol #: 207
C 1489 J. Prescott Vol #: 207
C 1490 A. Herrington Vol #: 207
C 1491 J. Preslar Vol #: 207
C 1492 S. Jung Vol #: 207
C 1493 J. Jackson Vol #: 207
C 1494 R. & S. Pearson Vol #: 207
C 1495 D. Mahnke Vol #: 207
C 1496 S. G. Borrillo Vol #: 207
C 1497 J. Walsh Vol #: 207
C 1498 K. Blaser Vol #: 207
C 1499 M. Watters Vol #: 207
C 1500 T. Jones Vol #: 207
C 1501 P. Petruccelli Vol #: 207
C 1502 C. Breedlove Vol #: 207
C 1503 M. Fitzgerald Vol #: 207
C 1504 L. Iachetta Vol #: 207
C 1505 M. Reardon Vol #: 207
C 1506 J. Campbell Vol #: 207
C 1507 S. Sarno Vol #: 207
C 1508 R. Hassinger Vol #: 207
C 1509 E. McCormick Vol #: 207
C 1510 L. Bostic Vol #: 207
C 1511 H. Ryan Vol #: 207
C 1512 P. Lopez Vol #: 207
C 1513 K. Logsdon Vol #: 207
C 1514 E. Harry Vol #: 207
C 1515 G. Mercury Vol #: 207
C 1516 K. Moore Vol #: 207
C 1517 T. Le Vol #: 207
C 1518 A. Baggett Vol #: 207
C 1519 R. Potter Vol #: 207
C 1520 E. Monsay Vol #: 207
C 1521 M. Royse Vol #: 207
C 1522 P. Rich Vol #: 207
C 1523 C. Patrick Vol #: 207
C 1524 P. Elsheimer Vol #: 207
C 1525 P. Sellers Vol #: 207
C 1526 W. Gilligan Vol #: 207
C 1527 M. Minard Vol #: 207
C 1528 R. Pastrana Vol #: 207
C 1529 W. L. Riviere Vol #: 207
C 1530 V. Hodge Vol #: 207
C 1531 S. Wheeler Vol #: 207
C 1532 M. J. Eberle Vol #: 207
C 1533 A. Leamon Vol #: 207
C 1534 G. Riker Vol #: 207
C 1535 M. Zoch Vol #: 207
C 1536 A. Tirrell Vol #: 207
C 1537 C. J. Miles Vol #: 207
C 1538 B. L. Wagoner Vol #: 207
C 1539 J. Fajardo Vol #: 207
C 1540 M. Hallisey Vol #: 207
C 1541 M. Cline Vol #: 207
C 1542 H. Stewart Vol #: 207
C 1543 V. Rogers Vol #: 207
C 1544 E. Vega Vol #: 207
C 1545 T. C. Yang Vol #: 207
C 1546 Y.M. Yang Vol #: 207
C 1547 K. Kroft Vol #: 207
C 1548 L. Scymanski Vol #: 207
C 1549 R. Messer Vol #: 207
C 1550 J. Shaffer Vol #: 207
C 1551 D. Mccaffrey Vol #: 207
C 1552 R. Kocsis Vol #: 207
C 1553 S. Gredzinski Vol #: 207
C 1554 J. Westmoreland Vol #: 207
C 1555 L. Brown Vol #: 207
C 1556 T. Gray Vol #: 207
C 1557 J. Burch Vol #: 207
C 1558 S. Collins Vol #: 207
C 1559 R. Doyle Vol #: 207
C 1560 A. Lowry Vol #: 207
C 1561 M. Rice Vol #: 207
C 1562 D. Phillips Vol #: 207
C 1563 K. Walkos Vol #: 207
C 1564 N. Funk Vol #: 207
C 1565 P. Bickett Vol #: 207
C 1566 B. Dyer Vol #: 207
C 1567 J. VanDruff Vol #: 207
C 1568 L. Quick Vol #: 207
C 1569 S. Oxx Vol #: 207
C 1570 I. Espinosa Vol #: 207
C 1571 D. Belusic Vol #: 207
C 1572 P. Schmidt Vol #: 207
C 1573 J. Farley-Rondon Vol #: 207
C 1574 P. Connolly Vol #: 207
C 1575 J. Gillman Vol #: 207
C 1576 B. Livingston Vol #: 207
C 1577 K. Moen Vol #: 207
C 1578 M. Maniscalco Vol #: 207
C 1579 S. Wood Vol #: 207
C 1580 L. Zeh Vol #: 207
C 1581 J. Hall Vol #: 207
C 1582 T. Young Vol #: 207
C 1583 M. Wartell Vol #: 207
C 1584 P. Woods Vol #: 207
C 1585 K. Hatzenbeler Vol #: 207
C 1586 A. McKendree Vol #: 207
C 1587 E. Sarantopoulos Vol #: 207
C 1588 R. Gentry Vol #: 207
C 1589 A. Duszenczuk Vol #: 207
C 1590 L. Schlossberg Vol #: 207
C 1591 A. Nudar Vol #: 207
C 1592 M. Stewart Vol #: 207
C 1593 J. Herbst Vol #: 207
C 1594 S. Musil-Buehler Vol #: 207
C 1595 D. Miller Vol #: 207
C 1596 T. & G. Easton Vol #: 207
C 1597 L.M. Brown Vol #: 207
C 1598 K. Chaney Vol #: 207
C 1599 T. Wellman Vol #: 207
C 1600 S. Mendelson Vol #: 207
C 1601 M. Yates Vol #: 207
C 1602 M. Winthrop Vol #: 207
C 1603 L. Whitley Vol #: 207
C 1604 R. Danis Vol #: 207
C 1605 L. Dunn Vol #: 207
C 1606 L. Lesh Vol #: 207
C 1607 J. Regan Vol #: 207
C 1608 A. Rabeuf Vol #: 207
C 1609 E. Nicolazzo Vol #: 207
C 1610 C. Tills Vol #: 207
C 1611 M. Larsen Vol #: 207
C 1612 J. Machmueller Vol #: 207
C 1613 D. Dayton Vol #: 207
C 1614 C. Bergener Vol #: 207
2003V-0550 Laser Light Show
ACK 2 FDA / DDM to Whatergy, Inc. Vol #: 1
VAR 2 Whatergy, Inc. Vol #: 1
2004N-0382 Food Labeling: Safe Handling Statements: Labeling of Shell Eggs
REF 2 OMB Review Vol #: 4
2004P-0006 Stay approval of abbreviated new drug applications for controlled release oxycodone hydrochloride products that list OxyContin oxycodone HCI controlled-release
ACK 2 FDA/DDM to Kleinfeld, Kaplan and Becker, LLP Vol #: 1
ACK 3 FDA/DDM to Kleinfeld, Kaplan and Becker, LLP Vol #: 1
CP 1 Kleinfeld, Kaplan and Becker, LLP Vol #: 2
PSA 2 Kleinfeld, Kaplan and Becker, LLP Vol #: 2
2005N-0272 Irradiation in the Production, Processing, and Handling of Food
C 44 T. Florczak Vol #: 1
C 45 C. Morrison Vol #: 1
C 46 C. Flaherty Vol #: 1
C 47 K. Yuhas Vol #: 1
C 48 D. Block Vol #: 1
C 49 L. Greub Vol #: 1
C 50 N. & R. Gott Vol #: 1
C 51 S. Knoploh-Odole Vol #: 1
C 52 K. Svet Vol #: 1
C 53 A. Colonna Vol #: 1
C 54 L. Lewis Vol #: 8
C 55 D. Ellenberg Vol #: 8
C 56 P. Michaels Vol #: 8
C 57 G. Field Vol #: 8
C 58 E. Wanning Vol #: 8
C 59 E. Pasquesi Vol #: 8
C 60 M. Zinn Vol #: 8
C 61 J. Abbey Vol #: 8
C 62 A. Adams Vol #: 8
C 63 S. Somes Vol #: 8
C 64 A. Vietor Vol #: 8
C 65 M. Franco Vol #: 8
C 66 J. Whatford Vol #: 8
C 67 Harvard Club of New York City Vol #: 8
C 68 Center for Neuromuscular Massage Therapy Vol #: 8
C 69 D. Lalani Vol #: 8
C 70 K. Little Vol #: 8
C 71 G. DiSpigno Vol #: 8
C 72 J. Jennings Vol #: 8
C 73 A. Adams Vol #: 8
C 74 P. Viethaler Vol #: 8
C 75 L. Bronstein Vol #: 8
C 76 N. Ross Vol #: 8
C 77 California Natural Products Vol #: 8
C 78 J. Mueller Vol #: 8
C 79 S. Mikolajczak Vol #: 8
C 80 K. Colebrook Vol #: 8
C 81 Rainbow Grocery Cooperative, Inc. Vol #: 8
C 82 D. & D. Luxern Vol #: 8
C 83 R. & J. Raleigh Vol #: 8
C 84 L. Colacurcio Vol #: 8
C 85 F. Hilton Vol #: 8
C 86 G. Barello Vol #: 8
C 87 A. Lewis Vol #: 8
C 88 J. Duncan Vol #: 8
C 89 M. Harris & J. Apodaca Vol #: 8
C 90 C. Cannon Vol #: 8
C 91 P. Shaia Vol #: 8
C 92 L. Black Vol #: 8
C 93 K. Wilkison Vol #: 8
C 94 S. Henderson Vol #: 8
C 95 Form Letter Count 77 Vol #: 10
C 96 Form Letter Count 7 Vol #: 11
C 97 Form Letter Count 16 Vol #: 12
C 98 N. Brown Vol #: 8
C 99 P. Pokorny Vol #: 8
C 100 W. Kobylarz Vol #: 8
C 101 Illegible Vol #: 8
C 102 J. Busch Vol #: 8
C 103 S. George Vol #: 8
EC 297 Ms. Gail Coffey Vol #: 6
EC 298 Ms. Valerie Guinan Vol #: 6
EC 299 Ms. Nancy Davenport Vol #: 6
EC 300 Mrs. Linda Nedderman-Eaton Vol #: 6
EC 301 Mr. David Purdy Vol #: 6
EC 302 Ms. Laura Smith Vol #: 6
REF 1 OMB Review Vol #: 9
2005N-0279 Food Labeling; Gluten-Free Labeling of Foods
REF 1 OMB Review Vol #: 37
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18316 R. Birckbichler Vol #: 198
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
C 17 American Clinical Laboratory Association (ACLA) Vol #: 1
2006D-0480 Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration
EC 212 individual consumer/grower Vol #: 6
EC 213 Mrs. Laurie Schober Vol #: 6
EC 214 Mr. Jeffrey Murrah Vol #: 6
EC 215 Mrs. Patricia Michael Vol #: 6
EC 216 Dr. Laurence Smith Vol #: 6
EC 217 Mr. Douglas Cook Vol #: 6
EC 218 Mr. Barry Corbett Vol #: 6
EC 219 Mrs. Desiree Passantino Vol #: 6
EC 220 Mr. Gerald Smagacz Vol #: 6
EC 221 Ms. Donna Guardino Vol #: 6
EC 222 Ms. Elaine La Rochelle Vol #: 6
EC 223 Mr. Hal Grisham Vol #: 6
EC 224 Finding Inner Peace Yoga School Vol #: 6
EC 225 none Vol #: 6
EC 226 Ms. Carol Hanson Vol #: 6
EC 227 Mrs. Nova ferguson Vol #: 6
EC 228 Mr. Peter Freer Vol #: 6
EC 229 Ms. claudia gehlhaart Vol #: 6
EC 230 Mr. Eric Wernli Vol #: 6
EC 231 Unique Logic Vol #: 6
EC 232 Ms. Ann Zavala Vol #: 6
EC 233 Miss. Catherine Shaffer Vol #: 6
EC 234 On Behalf of my family and me Vol #: 6
EC 235 Mr. Daniel Walsh Vol #: 6
EC 236 Mr. Richard Molini Vol #: 6
EC 237 Ms. A Fry Vol #: 6
EC 238 Ms. Lisa Thompson Vol #: 6
EC 239 Mr. Jerome Smith Vol #: 6
EC 240 Mrs. Catherine Comis Vol #: 6
EC 241 Mrs. Josephine Guardino Vol #: 6
EC 242 Mr. Richard Gray Vol #: 6
EC 243 Miss. Hannah Burns Vol #: 6
EC 244 Mr. Randall Bryant Vol #: 6
EC 245 Mrs. Kay Andresen Vol #: 6
EC 246 Mr. john nelson Vol #: 6
EC 247 Anti-Aging Clinic Assoc, Inc. Vol #: 6
EC 248 Ms. Leanne Wylet Vol #: 6
2006N-0238 Debarment of Maria Anne Kirkman Campbell
LET 3 FDA/CDER to Maria Anne Kirkman Campbell, M.D. Vol #: 1
2006N-0362 General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device
C 27 B. Ceverha Vol #: 1
2006P-0069 Health Claim Petition: Soluble Fiber from Certain Foods and Coronary Heart Disease
REF 1 OMB Review Vol #: 1
2006P-0334 Reclassification Petition fo Bone Heterografts
SUP 1 Regeneration Technologies Inc. Vol #: 1
2007D-0106 Guidance for Clinical Investigators, Sponsors, and IRBs on Adverse Event Reporting Improving Human Subject Protection
C 3 Consortium of Independent Review Boards Vol #: 1
2007D-0117 Guidance for Industry on Orally Disintegrating Tablets
C 7 Wyeth Pharmaceuticals, Inc. Vol #: 1
2007M-0108 P060019 - Therapy Cool Path Ablation Catheter and IBI 1500T9 RF Ablation Generator
NAL 1 FDA Vol #: 1
2007N-0114 Electronic Distribution of Prescribing Information for Prescription Drug Products; Public Hearing
TR 1 Transcript of April 27, 2007 Hearing Vol #: 3
2007N-0208 Interim Melamine and Melamine Analogues Safety/Risk Assessment; Availability
EC 1 B ACHAU Vol #: 1
2007P-0177 ANADA Suitability for generic new animal drug meloxicam which differs from the pioneer product, Metacam 1.5 mg/mL Oral Suspension
C 1 Boehringer Ingelheim Vetmedica, Inc. Vol #: 1

Page created on June 11, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management